Clinical Trial Update: A Window of Opportunity Trial: Avelumab in Non-metastatic Muscle Invasive Bladder Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial of avelumab in non-metastatic muscle-invasive bladder cancer was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Invasive Bladder Cancer
• Muscle-invasive Bladder Cancer

Drugs mentioned

• Avelumab (avelumab)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Bladder Cancer, Metastatic Bladder Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-08-24